BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1182692)

  • 1. Tissue-specific synthesis of methotrexate polyglutamates in the rat.
    Whitehead VM; Perrault MM; Stelcner S
    Cancer Res; 1975 Nov; 35(11 Pt 1):2985-90. PubMed ID: 1182692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential synthesis of methotrexate polyglutamates in normal proliferative and neoplastic mouse tissues in vivo.
    Poser RG; Sirotnak FM; Chello PL
    Cancer Res; 1981 Nov; 41(11 Pt 1):4441-6. PubMed ID: 6171339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrolytic cleavage of methotrexate gamma-polyglutamates by folylpolyglutamyl hydrolase derived from various tumors and normal tissues of the mouse.
    Samuels LL; Goutas LJ; Priest DG; Piper JR; Sirotnak FM
    Cancer Res; 1986 May; 46(5):2230-5. PubMed ID: 2421872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ methotrexate polyglutamate formation in rat tissues.
    Krakower GR; Kamen BA
    J Pharmacol Exp Ther; 1983 Dec; 227(3):633-8. PubMed ID: 6197519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of the poly-gamma-glutamyl metabolites of methotrexate in skin and other tissues of rats and hairless mice.
    Zimmerman CL; Franz TJ; Slattery JT
    J Pharmacol Exp Ther; 1984 Nov; 231(2):242-7. PubMed ID: 6208357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the in vivo synthesis of methotrexate polyglutamates and their efflux properties in normal, proliferative, and neoplastic mouse tissues.
    Poser RG; Sirotnak FM
    Adv Exp Med Biol; 1983; 163():259-74. PubMed ID: 6193689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyglutamation of the antifolate anticancer drug N10-propargyl-5,8-dideazafolic acid (CB 3717) in the mouse.
    Manteuffel-Cymborowska M; Sikora E; Grzelakowska-Sztabert B
    Anticancer Res; 1986; 6(4):807-12. PubMed ID: 2875688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic parenchymal cell glutamylation of methotrexate studied in monolayer culture.
    Galivan J; Pupons A; Rhee MS
    Cancer Res; 1986 Feb; 46(2):670-5. PubMed ID: 2416430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of folinic acid on hepatoma cells containing methotrexate polyglutamates.
    Galivan J; Nimec Z
    Cancer Res; 1983 Feb; 43(2):551-5. PubMed ID: 6184149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of methotrexate to 7-hydroxymethotrexate and 7-hydroxymethotrexate polyglutamates in cultured rat hepatic cells.
    Rhee MS; Galivan J
    Cancer Res; 1986 Aug; 46(8):3793-7. PubMed ID: 2425934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of polyglutamates in methotrexate action.
    Wilmanns W; Schalhorn A
    Chemioterapia; 1985 Oct; 4(5):349-53. PubMed ID: 2416481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro approach to 7-hydroxymethotrexate interaction on methotrexate metabolism as tool of pharmacokinetic study.
    Fabre G; Cano JP; Catalin J; Just S
    Int J Clin Pharmacol Res; 1983; 3(6):475-84. PubMed ID: 6590470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formation.
    Jolivet J; Cole DE; Holcenberg JS; Poplack DG
    Cancer Res; 1985 Jan; 45(1):217-20. PubMed ID: 2578094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and biological studies on 2-desamino-2-methylaminopterin, an antifolate the polyglutamates of which are more potent than the monoglutamate against three key enzymes of folate metabolism.
    Rosowsky A; Galivan J; Beardsley GP; Bader H; O'Connor BM; Russello O; Moroson BA; DeYarman MT; Kerwar SS; Freisheim JH
    Cancer Res; 1992 Apr; 52(8):2148-55. PubMed ID: 1313737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental study on pharmacokinetics of methotrexate and its metabolite (7-hydroxy-methotrexate) in tissue].
    Sasaki K; Hosoya R; Wang YM; Sutow WW; Fujimoto T
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1678-87. PubMed ID: 7184366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of human cellular gamma-glutamyl hydrolase.
    Rhee MS; Lindau-Shepard B; Chave KJ; Galivan J; Ryan TJ
    Mol Pharmacol; 1998 Jun; 53(6):1040-6. PubMed ID: 9614206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of folinic acid and glycine, adenosine, and thymidine as rescue agents in methotrexate-treated human cells in relation to the accumulation of methotrexate polyglutamates.
    Rosenblatt DS; Whitehead VM; Matiaszuk NV; Pottier A; Vuchich MJ; Beaulieu D
    Mol Pharmacol; 1982 May; 21(3):718-22. PubMed ID: 6180291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regiospecific gamma-conjugation of methotrexate to poly(L-lysine). Chemical and biological studies.
    Rosowsky A; Forsch RA; Galivan J; Susten SS; Freisheim JH
    Mol Pharmacol; 1985 Jan; 27(1):141-7. PubMed ID: 3965926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.